Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial
伊布替尼联合利妥昔单抗对比免疫化疗治疗既往未接受治疗的套细胞淋巴瘤患者（ENRICH）：一项随机、开放标签、2/3期优效性试验
期刊:Lancet
影响因子:88.5
doi:10.1016/S0140-6736(25)01432-1
Lewis, David J; Jerkeman, Mats; Sorrell, Lexy; Wright, David; Glimelius, Ingrid; Poulsen, Christian B; Pasanen, Annika; Rawstron, Andrew; Wader, Karin F; Morley, Nick; Burton, Catherine; Davies, Andrew J; Lagerlöf, Ingemar; Dalal, Surita; De Tute, Ruth; McNamara, Chris; Crosbie, Nicola; Toldbod, Helle Erbs; Sanders, Jeanette; Allgar, Victoria; Aroori, Sree; Warner, Mark; Scully, Claire; Wainman, Brian; Christensen, Jacob Haaber; Riise, Jon; Sonnevi, Kristina; Bishton, Mark J; Eyre, Toby A; Rule, Simon
